Skip to main content
Clinical Trials/NCT06745427
NCT06745427
Not Yet Recruiting
N/A

A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

Region Stockholm0 sites100 target enrollmentJanuary 15, 2025

Overview

Phase
N/A
Intervention
Not specified
Conditions
Endometrial Cancer
Sponsor
Region Stockholm
Enrollment
100
Primary Endpoint
Relaps of endometrial cancer or EIN after fertility-sparing treatment
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia

Detailed Description

A multi-center prospective study on the oncological and reproductive outcomes and quality of life in young woman after fertility-sparing treatment of endometrial cancer and endometrial intraepithelial hyperplasia

Registry
clinicaltrials.gov
Start Date
January 15, 2025
End Date
January 15, 2030
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Charlotta Riese

MD

Region Stockholm

Eligibility Criteria

Inclusion Criteria

  • Fertility sparing treatment of EC and EIN.
  • 18-45 Years old
  • From start study (Jan 2025 - end study Jan 2028)
  • All centras in Sweden

Exclusion Criteria

  • Not English och Swedish speaking

Outcomes

Primary Outcomes

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Time Frame: from enrollment to 2 years after fertility-sparing treatment

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Secondary Outcomes

  • Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN(From start of study to 2 years after fertility-sparing treatment)

Similar Trials